New CRTh2 antagonists

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

Saved in:
Bibliographic Details
Main Authors VIDAL JUAN, BERNAT, ROBERTS, RICHARD SPURRING, BUIL ALBERO, MARIA ANTONIA, EASTWOOD, PAUL ROBERT, ESTEVE TRIAS, CRISTINA, ALONSO DIEZ, JUAN ANTONIO, LOZOYA TORIBIO, MARIA ESTRELLA, MIR CEPEDA, MARTA, VIDAL GISPERT, LAURA, GONZALEZ RODRIGUEZ, JACOB
Format Patent
LanguageChinese
English
Published 01.02.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
Bibliography:Application Number: TW20120124389